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There are a number of controversies relating to studies of 
bullous pemphigoid (BP) antigens from different institu-
tions, mainly regarding the detection of the 230-kD and 
170-kD BP antigens. In this study, in an attempt to resolve 
the discrepancies, we have examined and compared the reac-
tivity by immunofluorescence, immunoblotting, and immu-
noprecipitation among the sera from Japanese, British and 
U.S. BP patients. Both the 230-kD and 170-kD BP antigens 
were detected by various sera from all populations with im-
munoblotting, whereas immunoprecipitation detected only 
the 230-kD BP antigen but not the 170-kD BP antigen. 
Immunoprecipitation was more sensitive than immunoblot-
ting to detect the 230-kD antigen. These results indicate that 
T he presence of anti-epidermal basement membrane zone (BMZ) autoantibodies is now a hallmark in the diagnosis of bullous emphigoid (BP) [1,2] . The BP antigens that are deAned immunologically by anti-BMZ antibodies have been extensively investigated 
[3 - 24], althoug~l there are still .some controversies in studies .from 
different 1I1stltutlons. Some studies have suggested that BP antibod-
ies recognize a single antigen [3 - 7], whereas others have indicated 
that there may be molecular heterogeneity in BP antigens [8 - 17]. 
In general. BP antigen was identified as a unique 230-kD protein by 
immunoprecipitation [3-6]. However, immunoblot analYSIS 
showed several different BP antigens, mainly the 230-kD and 170-
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Abbreviations: 
BMZ: basement membrane zone 
BP: bullous pemphigoid 
BSA: bovine serum albumin 
EDTA: ethylenediaminetetraacetic acid 
PMSF: phenylmethylesulfonyl fluoride 
SDS-PAGE: sodium dodecylsulfate-polyacrylamide gel electro-
phoresis 
TBS: Tris-HCI- - buffered saline, pH 8.0 
?oth the 230-kD and 170-kD proteins are BP antigens found 
111 all three populations. By immunofluorescence cell surface 
staining in the lower epidermis in addition to basement 
membrane zone staining was shown by a considerable num-
ber of patients ' sera in all populations. Comparison between 
the results of immunofluorescence and immunoblotting re-
vealed a clear correlation of this cell surface staining with the 
presence of antibodies against the 170-kD BP antigen. That 
the affinity-purified antibodies specific to the 170-kD BP 
antigen showed this cell surface staining further confirmed 
this correlation. These results may indicate a different nature 
of the 170-kD BP antigen from that of the 230-kD BP anti-
gen. ] Invest Dermatol1 00:385 -389, 1993 
kD proteins [9 - 17]. Furthermore, the frequency of detection of the 
2?0-kD and 1?0-kD BP antigens is considerably different among 
d~ffenng studl~s [9 -17]. These discrepancies may be due to the 
different techl11ques used. Another possibility is that there may be 
different subsets of BP patients in differing populations. 
. T? clarify these dl~crepancies , we examined the sera from patients 
111 dlffere~t population groups by immunofluorescence. immuno-
blot, a~d Immunoprecipitation assays. No obvious difference was 
found I? the result.s for each group of patients. Furthermore, the 
correlation of the Immunofluorescence results with those of im-
munoblotting indica.ted the possibility that the antibodies agains t 
th~ ~ 70-.kD BP antigen may be responsible for the cell surface 
sta1l1111g 111 the lower epidermis. 
MATERIALS AND METHODS 
Sera .Sera were obtained from 35 J apanese BP patients. 29 British 
BP patients, 11 U .S. BP patients, and 10 normals. All sera were 
stored at-20°C or stored at4°C in the presence of 0.1% NaNJ for 
less than 1 month during these experiments. 
Immunofluorescence Indirect immunofluorescence was per-
formed by standard method [1] using normal human skin section as 
a substrate. To remove the antibodies against blood type antigens, 
some BP sera were pre-absorbed with an eightfold volume of red 
blood cell pellet of AB type at room temperature for 2 h before 
immunofluorescence. 
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Figure 1. Results of immunofluorescence. A: The serum of u.s. BP pa-
tient AS that reacted only with the 170-kD BP antigen with immunoblot-
ting stained the cell surface in the lower epidennis as well as the BMZ 
(magnification X400). E and D, epidennis and dennis, respectively. B: 
The serum of British BP patient Bl reactive only with the 230-kD BP 
antigen stained only the BMZ (magnification X400). C: The serum of AS 
also stained the cell surface of the tumor cells of hydroacanthoma simplex 
(magnification X 400). Bar, 10 ).lm. 
Immunoblot Analysis Immunoblots with ethylenediaminete-
traacetic acid (EDT A)-separated normal human epidermal extracts 
were performed as described previously [10]. 
Immunoprecipitation lmmunoprecipitation was rerformed 
mainly according to the method described previously [3 . We used 
KUS cells, a human squamous cell carcinoma cell line originating 
from a penile carcinoma [25]. KU8 cells were radiolabeled with 
35S-methionine (0.925 X 106 Bqjml) in methionine-free medium 
cont;tining 10% fetal calf serum, and lysed with 0 .5% Noni-
det P-40 in the Tris-HCI- buffered saline (TBS, pH 8.0) supple-
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Figure 2. Results of immunoblot analyses. The reactivity of five repre-
sentative BP sera each of U.K. (lan es B1-B5), U.S. (la"es A1-A5), and 
Japan (Iafles J1 -]3,]7, and J8), and one normal serum (lane C) is depicted. 
The number shown beneath each lane corresponds to the same number in 
Fig 3. The positions of the 230-kD and 170-kD BP antigens are shown to 
the left. The migrations of standard molecular markers are shown to the 
right. The positions of the both BP antigens in each set of five lanes are 
connected by hariza" tal bars. Most BP sera reacted with the 230-kD and/or 
the 170-kD BP antigens in a variety of patterns. The 230-kD BP antigen 
was detected as a doublet of protein bands in this particular experiment. 
mented with 2 mM phenylmethylsulfonyl fluoride (PMSF). After 
centrifugation at 10,000 X g at 4 a C for 40 min, the supernatant was 
dialyzed against TBS containing 0.3% Nonidet P-40 and 2 mM 
PMSF overnight, and stored at -80 a C as aliquots. To reduce non-
specific background, a 200-,u1 antigen sample (2.4 - 3.6 X 107 cpm) 
was first pre-absorbed with 20 ,ul of combined sera from three nor-
mal subjects at 4 a C overnight, and then precipitated by incubation 
with 60,u1 of Protein G Sepharose slurry (Pharmacia, Uppsala, 
Sweden) at 4 a C for 30 min. Fifteen microliters pre-absorbed anti-
gen sample was incubated with 3 ,ul of either BP or normal sera at 
4 ac overnight. Antigen-antibody complexes were precipitated by 
incubation with 3 ,ul Protein G Sepharose slurry at 4 a C for 30 min. 
After the precipitates were washed six times with TBS containing 
0.3% Nonidet P-40, 0.3% sodium deoxycholate, and 2 mM PMSF, 
Protein G, IgG, and antigens were dissociated and reduced by boil-
ing in Laemmli's sample buffer (0.00625 M Tris-HCI, pH 6.S, 
containing 2% sodium dodecylsulfate (SDS) and 5% p-mercap-
toethanol), and Protein G was removed by centrifugation. After 
proteins were fractionated by SDS - polyacrylamide gel electropho-
resis (PAGE), gels were processed for fluorography. 
Affinity-Purification of Autoantibodies According to the pre-
viously reported method [16), autoantibodies were affinity purified 
from nitrocellulose membrane. Briefly, horizontal strips containing 
appropriate antigens were cut from membrane blotted with SDS-
PAGE fractionated epidermal extracts, blocked with 3% skim milk 
in TBS, incubated with a BP serum and extensively washed. Bound 
antibodies were eluted for 30 min at 37"C with 20 mM sodium 
citrate (pH 3.2) containing 0.5% bovine serum albumin (BSA) and 
0.05% Tween 20, neutralized with 2 M Tris-HCI (pH 7.5), dia-
lyzed against TBS, concentrated, and subjected to immunofluores-
cence. Another horizontal strip from unrelated area of the same 
Table I. Summary of the Results of Immunoblotting 
lmmunoblot Japan U.K. U.s.A. Total 
230 kD only (+) 10 10 8 28 
170 kD only (+) 9 8 2 19 
Both (+) 16 7 0 23 
Both (-) 0 4 1 5 
Total 35 29 11 75 
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Figure 3. Results of imrnunoprecipitation for 10 representative BP sera each of threepopulation groups. The position of the 230·kD BP antigen and the 
level where the 170-kD BP antigen is supposed to migrate are shown to the left. The nugrations of standard molecular markers are shown to the right. The 
positions of the 230-kD and 170-kD BP antigens are connected by horizolltal bars. Two protein bands of high molecular weight and approximately 200 kD 
(shown by Opell circles to the right of each set of 10 lanes) constantly seen in our imrnunoprecipitation were considered non-specific, because the protein 
bands were seen even in normal control serum (lane C) . The 230-kD BP antigen was detected by most BP sera, although any sera showed no specific 
protein band corresponding to the 170-kD protein. 
nitrocellulose membrane was similarly processed, and the eluate 
was used as a negative control. 
RESULTS 
ltnmunofluorescence With immunofluorescence of normal 
human skin sections, all patients' sera showed anti-BMZ antibodies 
at a titer of 1 : 20 or more. Furthermore, reactivity with the cell 
surface in the lower epidermis was also seen in the sera of 23 BP 
patients (IS of 35 Japanese patients, six of 29 British patients, and 
two of 11 U.S. patients). The intensity of the reactivity was vanable. 
Although 18 sera reacted with only the lateral or entire cell surface 
of basal cells, five sera showed the cell surface staining in the two to 
three cell layers of the lower epidermis (Fig l A ,B). Because the cell 
surface staining seemed to be restricted to the lower undifferen-
tiated cells in the epidermis, we also used cryostat sections from a 
case of hydroacanthoma simplex, a benign skin tumor derived from 
intraepidermal eccrine sweat duct, in which tumor cells show simi-
lar appearance to basal cells. When this section was used as a sub-
strate, 12 of these 23 BP sera showed strong reactivity with the cell 
surface of all tumor cells (Fig 1 C). To rule out the possibility that 
this cell surface staining was due to anti-blood type antibodies, we 
pre-absorbed these sera with red blood cells of type AB before immu-
nofluorescence. No reduction of the cell surface reactivity was seen 
in any sera after th e pre-absorption. Some sera showed cytoplasmic 
staining of basal cells, which was easily distinguished from the cell 
surface staining by its different staining pattern. 
ltnmunoblot Analysis With immunoblotting, most BP sera la-
beled the two known BP antigens, i.e., the 230-kD and 170-kD 
proteins, in a variety of patterns (Fig 2 and T able I). Both the 
230-kD and 170-kD BP antigens were detected by sera of BP pa-
tients in all three populations. However, an apparent difference 
noted was that although the 170-kD BP antigen was detected by a 
majority of the sera from Japanese and British patients, only two of 
Table II. Relationship of Detection of the 230-kD BP Antigen 
Between Immunoblotting and Immunoprecipitation 
lrnmunoblot lmmunoprecipitation Japan U.K. U.s .A. Total 
230 kD (+) 
230 kD (-) 
Total 
230 kD (+) 
230 kD (- ) 
230 kD (+) 
230 kD (-) 
26 
o 
o 
9 
35 
9 
o 
2 
5 
16 
8 
o 
2 
1 
11 
43 
o 
4 
15 
62 
11 sera reacted with the 170-kD BP antigen in U.S. patients. The 
patterns of re~ctivity were otherwise almost identical among the 
three populations. Ten control sera did not show either of these 
protein bands. 
Immunoprecipitation All sera from J apanese and U.S. BP pa-
tients and 16 of29 British BP patients were examined by immuno-
precipitation. Forty-seven of 62 tested sera precipitated the 230-kD 
BP antigen (Fig 3). However, none of th e patients' sera precipitated 
the protein corresponding to the 170-kD BP antigen. None of the 
seven control sera that were not used for pre-clearance of the cell 
extracts showed any specific reactivity either. The correlation of 
detection of the 230-kD BP antigen between immunoblotting and 
immunoprecipitation is summarized in Table II. All 43 BP sera that 
detected the 230-kD BP antigen with immunoblotting also immu-
noprecipitated the 230-kD protein. However, four of 19 BP sera 
that did not detect the 230-kD BP antigen by immunoblotting did 
Imm~nopreClpltate the 230-kD protein, although the remaining 15 
s~ra did not detect the 230-kD protein even with immunoprecipita-
tlOn. 
Relationship Between the Results of Immunofluorescence 
and Immunoblotting Table III summarizes the relation of the 
patten~ of.reactivity with immunoblotting to the cell surface stain-
mg With ullmunofluorescence. Surprisingly, all the 23 sera that 
showed the cell surface staining with immunofluorescence detected 
the. 170-kD BP anti~ell with immunoblotting, although the re-
mamll1g 19 ser~ reactive With the 170-kD protein did not show the 
cell surface stammg. By contrast, any sera that did not detect the 
Table III. Relationship Between the Results in 
Imrnunoblotting and the Cell Surface Staining 
with Immunofluorescence 
Cell Surface 
Immunoblot 
Staining with 
Immunofluorescence Japan U.K. U.S.A. Total 
230 kD only (+) (+) 0 0 0 0 
(-) 10 10 8 28 
170 kD only (+) (+) 7 6 2 15 
(- ) 2 2 0 4 
Both (+) (+) 8 a 0 8 
(-) 8 7 0 15 
Both(- ) (+) 0 0 0 0 
(-) 0 4 1 5 
Total 35 29 11 75 
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Figure 4. Reactivity of affinity-purified antibodies on immunofluores-
cence. A: The eluate from the 170-kD BP antigen stained the cell surface 
in the lower epidermis as well as the BMZ (magnification X 400). E and D, 
epidermis and dermis, respectively. B: The eluate from the 230-kD BP 
antigen showed only the BMZ staining (magnification X400). Bar, 10 j1m. 
170-kD BP antigen with immunoblotting did not show the cell 
surface staining. The cell surface staining was shown by as many as 
15 of 19 sera that reacted only with the 170-kD protein, whereas 
only eight of23 sera that reacted with both the 230-kD and 170-kD 
proteins showed the cell surface staining. This tendency was almost 
the same among the three populations. There is no correlation be-
tween the immunofluorescence titer of sera and the cell surface 
staining. Some BP sera with low titer (around 1 : 40) showed the cell 
surface staining, and many sera with high titer (> 1 : 640) did not 
show the staining. 
Reactivity of Aflinity-Puri6ed Antibodies From a Japanese 
BP patient's serum ("J2" shown in Fig 2 and Fig 3) that clearly 
stained the cell surface in the lower epidermis with immunofluores-
cence and labeled both the 230-kD and 170-kD BP antigens with 
immunoblotting, autoantibodies specific either to the 230-kD BP 
antigen or to the 170-kD BP antigen were affinity purified and 
examined by immunofluorescence. The eluate from the 170-kD BP 
antigen stained the cell surface in the lower epidermis as well as the 
BMZ (Fig 4A). In contrast, the eluate from the 230-kD BP antigen 
showed only the BMZ staining (Fig 4B). The eluate from unrelated 
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area of nitrocellulose membrane did not show any specific staining 
(not shown). 
DISCUSSION 
In the present study, we found several interesting results by compar-
ing the reactivity in three different assays among BP patients of 
three different population groups. 
Although the 170-kD BP antigen has been frequently detected in 
many studies [9 - 17], some reports, mainly from U.S. investigators, 
include no description for the 170-kD BP antigen, even with im-
munoblot studies [3 - 7]. In this study, we found the 170-kD BP 
antigen-positive sera in all groups of BP patients including U.S., 
indicating that the 170-kD protein is one of the BP antigens in all 
tested populations. The lack of reactivity of the 170-kD BP antigen 
by immunoblotting from some institutions may be due to differ-
ences in the techniques used. One possible reason is that proteinase 
inhibitors may not be adequate, if the 170-kD BP antigen is particu-
larly sensitive to proteinase. 
Although immunoblot assay has clearly demonstrated the 170-
kD BP antigen [9 -17], the 170-kD protein has not been reported to 
be detectable with immunoprecipitation [3 - 6]. In this study, we 
could not detect the 170-kD protein with our immunoprecipita-
tion, even with the BP sera that showed strong reactivity with the 
170-kD protein by immunoblotting. It has been reported that a 
faint 166-kD protein band was occasionally seen with immunopre-
cipitation [8]. This 166-kD protein may be the same as the 170-kD 
BP antigen. However, because this protein was always associated 
with the more prominent 230-kD protein, the 166-kD protein may 
also be a degradation product of the 230-kD protein but not the 
170-kD BP antigen. The reason why the 170-kD BP antigen is not 
detected by immunoprecipitation is at present unknown. 
A previous study reported that immunoprecipitation is more sen-
sitive than immunoblotting [8]. In that study, the 230-kD BP anti-
gen was detected by almost all BP sera, whereas some sera did not 
detect the 230-kD protein by immunoblotting. In the present study, 
we also found that all BP sera reactive with the 230-kD BP antigen 
with immunoblotting immunoprecipitated the same protein and, 
furthermore, some sera negative for the 230-kD protein with im-
munoblotting clearly demonstrated the antigen with immunopre-
cipitation. This confirms that immunoprecipitation is more sensi-
tive than immunoblotting for detection of the 230-kD BP antigen. 
In general, the present study indicates that there is similar reactiv-
ity of BP sera among the three different population groups. The 
discrepancies found in previous reports are most likely to be due to 
the different techniques used in individual institutions. This indi-
cates that the use of standardized techniques among different labora-
tories may be required for future progress in the investigation ofBP 
antigens. 
A surprising result obtained during this investigation was a close 
relationship between the cell surface staining with immunofluores-
cence and the presence of the antibodies to the 170-kD BP antigen. 
We previously noticed that a few BP sera react with the ceJl surface 
in the lower epidermis as well as the BMZ [26,27]. In the present 
study, we found 23 of 75 BP sera demonstrated the cell surface 
staining in the lower epidermis. All the sera showing the cell surface 
staining detected the 170-kD BP antigen by immunoblotting, 
whereas the cell surface staining was not shown by any sera negative 
for the 170-kD BP antigen. These results strongly suggest that 
antibodies against the 170-kD BP antigen are responsible for the 
cell surface staining. This speculation was further confirmed by the 
results of the study using affinity-purified antibodies that the anti-
bodies specific to the 170-kD BP antigen stained the cell surface in 
the lower epidermis as well as the BMZ, whereas the antibodies 
specific to the 230-kD BP antigen showed only the BMZ staining. 
Most BP sera reactive only with the 170-kD BP antigen showed 
the cell surface staining, whereas fewer of the sera reactive with 
both the 230-kD and 170-kD BP antigens showed this pattern of 
staining. The reason for this is at present unknown. 
Recently, cDNA cloning indicated that the 170-kD BP antigen 
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has a quite unique structure with the characteristics of a collagen 
molecule [23 ,24]. Our results in the present study further suggest 
the different nature of the 170-kD BP antigen from that of the 
230-kD BP antigen. In future, consideration of the possible localiza-
tion of the 170-kD BP antigen in the cell surface of the lower 
epidermis may give some insights for the studies of this protein. 
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